Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.
Ochiai R, Hayashi K, Yamamoto H, Fujii R, Saichi N, Shinchi H, Ishida T, Honda T, Shimizu T, Matsutani N, Seki N, Kawamura M, Ueda K.
Ochiai R, et al. Among authors: kawamura m.
Cancer Sci. 2022 Nov;113(11):3960-3971. doi: 10.1111/cas.15512. Epub 2022 Aug 26.
Cancer Sci. 2022.
PMID: 36028467
Free PMC article.